1Kahilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial[J]. Aliment Pharmacol Ther, 2000,14 : 1249-1258. 被引量：1
1Jafri N, Jafri W, Yakoob J, et al. Perception of gastroesopha- geal reflux disease in urban population in Pakistan[J]. Coil Physicians Surg Pak, 2005,15(9) : 532-534. 被引量：1
2Chen M, Xiong L, Chen H, et al. Prevalence risk factors and impact of gastroesophageal reflux disease symptoms: a popula- tion-based study in South China[J]. Scand J Gastroenterol, 2005,40(7) :759-767. 被引量：1
3Block G, Woods M, Potosky A, et al. Validation of a self ad ministered diet history questionnaire using multiple diet re- cords[J]. J Clin Epidemiol, 1990,43(12) :1327-1335. 被引量：1
4Armstrong D, Bennett JR, Blum AL,et al. The endoscopic assessment of esophagitis: a progress report on observer a- greement[J]. Gastroenterology, 19 9 6,111 ( 1 ) : 8 5-9 2. 被引量：1
5He J, Ma XQ, Zhao YF, et al. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematie investigation of gastrointestinal disea- ses in China[J]. BMC Gastroenterol, 2010,10 (2) : 94 -103. 被引量：1
6Seiji A, Tornohiro K, Kyoko I, et al. Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms[J]. J Clin Biochem Nutr, 2012, 50(3):205-210. 被引量：1
7Fujiwara Y, Arakawa T, Fass R. Gastroesophageal reflux disease and sleep disturbances[J]. J Gastroenterol, 2012,47 (7) :760-769. 被引量：1
8Yamamichi N, Mochizuki S, Asada-Hirayama I, et al. Lifes- tyle factors affecting gastroesophageal reflux disease symp- toms: a cross-sectional study of healthy 19864 adults using FSSG scores[J]. BMC Med,2012, 3(10) :45. 被引量：1
9Vega KJ, Chisholm S, Jamal MM. Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites[J]. World J Gastroenterol, 2000, 15(23) :2878-2881. 被引量：1
